Cargando…
26. Risk of Post–COVID-19 Dyspnea and Interstitial Lung Disease (ILD) in a Real-World Cohort of Patients Hospitalized with COVID-19 in the United States
BACKGROUND: While COVID-19 carries substantial morbidity and mortality, the extent of long-term complications remains unclear. Reports suggest that acute lung damage associated with severe COVID-19 can result in chronic respiratory dysfunction. This study: (1) estimated the incidence of dyspnea and...
Autores principales: | Zalocusky, Kelly, Chawla, Devika, Neighbors, Margaret, Rizzo, Shemra, Tsai, Larry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644584/ http://dx.doi.org/10.1093/ofid/ofab466.026 |
Ejemplares similares
-
515. Evolution of Treatment Patterns for Patients Hospitalized with COVID-19 in the United States
por: Zalocusky, Kelly, et al.
Publicado: (2021) -
281. Prevalence of Influenza Co-infection in a Real-world Cohort of COVID-19 Patients in the U.S
por: Chawla, Devika, et al.
Publicado: (2021) -
322. Risk Factors for COVID-19 Disease Severity Using Electronic-Health Records in a Real-World Cohort in the United States
por: Rizzo, Shemra, et al.
Publicado: (2021) -
Severity of COVID-19 and adverse long-term outcomes: a retrospective cohort study based on a US electronic health record database
por: Jovanoski, Nick, et al.
Publicado: (2021) -
Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity
por: Mehta, Puja, et al.
Publicado: (2022)